|
1
|
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
|
Arch Gen Psychiatry
|
2010
|
3.88
|
|
2
|
The environment and schizophrenia: the role of cannabis use.
|
Schizophr Bull
|
2005
|
1.90
|
|
3
|
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.
|
World Psychiatry
|
2005
|
1.52
|
|
4
|
The COMT val158met polymorphism and brain morphometry in healthy young adults.
|
Neurosci Lett
|
2006
|
1.25
|
|
5
|
Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome.
|
Schizophr Res
|
2004
|
1.22
|
|
6
|
Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.
|
Can J Psychiatry
|
2004
|
1.15
|
|
7
|
Disability in people clinically at high risk of psychosis.
|
Br J Psychiatry
|
2010
|
1.10
|
|
8
|
Attitudes of patients toward the first psychotic episode and the start of treatment.
|
Schizophr Bull
|
2002
|
1.09
|
|
9
|
Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
|
Schizophr Res
|
2012
|
1.04
|
|
10
|
Ultra high-risk state for psychosis and non-transition: a systematic review.
|
Schizophr Res
|
2011
|
1.02
|
|
11
|
A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial.
|
Trials
|
2010
|
1.01
|
|
12
|
White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia.
|
Schizophr Res
|
2011
|
0.94
|
|
13
|
Antisaccade task performance in patients at ultra high risk for developing psychosis.
|
Schizophr Res
|
2007
|
0.94
|
|
14
|
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
|
Am J Psychiatry
|
2003
|
0.93
|
|
15
|
Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
|
J Clin Psychiatry
|
2002
|
0.90
|
|
16
|
Obsessive-compulsive symptoms and positive, negative, and depressive symptoms in patients with recent-onset schizophrenic disorders.
|
Can J Psychiatry
|
2005
|
0.87
|
|
17
|
Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
|
J Psychopharmacol
|
2011
|
0.85
|
|
18
|
Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.
|
Psychoneuroendocrinology
|
2009
|
0.85
|
|
19
|
Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.
|
PLoS One
|
2011
|
0.85
|
|
20
|
Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.
|
Neuropsychopharmacology
|
2007
|
0.84
|
|
21
|
Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up.
|
Soc Psychiatry Psychiatr Epidemiol
|
2012
|
0.84
|
|
22
|
Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study.
|
J Psychopharmacol
|
2010
|
0.83
|
|
23
|
Subjective experiences during dopamine depletion.
|
Am J Psychiatry
|
2005
|
0.83
|
|
24
|
Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis.
|
Psychiatry Res
|
2013
|
0.83
|
|
25
|
Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial.
|
Can J Psychiatry
|
2008
|
0.82
|
|
26
|
Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders.
|
Eur Psychiatry
|
2004
|
0.80
|
|
27
|
Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study.
|
Eur Neuropsychopharmacol
|
2013
|
0.79
|
|
28
|
The trainee project: family-aided vocational rehabilitation of young people with schizophrenia.
|
Psychiatr Rehabil J
|
2002
|
0.78
|
|
29
|
Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets.
|
Psychopharmacology (Berl)
|
2004
|
0.77
|
|
30
|
Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis.
|
Psychol Assess
|
2010
|
0.77
|
|
31
|
Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
|
Psychiatry Res
|
2007
|
0.77
|
|
32
|
Perceived negative attitude of others as an early sign of psychosis.
|
Eur Psychiatry
|
2009
|
0.77
|
|
33
|
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia.
|
Psychopharmacology (Berl)
|
2005
|
0.76
|
|
34
|
Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis.
|
J Clin Psychopharmacol
|
2008
|
0.76
|
|
35
|
Visual scan paths in young patients with schizophrenia, healthy siblings and controls.
|
Schizophr Res
|
2006
|
0.76
|
|
36
|
Field testing attenuated psychosis syndrome criteria.
|
Am J Psychiatry
|
2011
|
0.75
|
|
37
|
Blinding in clozapine trials: a problem and a potential solution.
|
Int J Methods Psychiatr Res
|
2009
|
0.75
|
|
38
|
Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics.
|
Am J Psychiatry
|
2005
|
0.75
|
|
39
|
Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up.
|
J Nerv Ment Dis
|
2011
|
0.75
|